Commercial Medical Devices

MHRA Opens Community of Practice for Digital Mental Health Technologies

The UK regulator pairs a shared-learning forum for developers, clinicians and regulators with a sector survey intended to set its first priorities.

SH
Samira Hale
Infection Control, Quality and Procurement Editor
October 22, 2026
5 min read
9 views
Concept illustration of developers, clinicians and regulators gathered around abstract connected nodes, reflecting the shared-learning forum the MHRA has set up for digital mental health technologies.
Abstract figures of a developer, a clinician and a regulator meet around a table holding a translucent network diagram, with a wall display of blurred interface panels behind them.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies, intended to build shared regulatory understanding and practical support for developers in one of the fastest-growing areas of UK medtech.

Published on the MHRA's official blog, the announcement sets out a coordinated effort to help innovators interpret regulatory expectations, improve compliance and move safe, effective digital mental health products into clinical use. The agency presents the move as a response to rising demand for clarity on evidence requirements, post-market responsibilities and the changing regulatory landscape for software-based and AI-enabled mental health tools.

Participants and stated objectives

The community is meant to bring developers, clinicians, researchers, commissioners and regulatory specialists together so that best practice is understood in common terms, across a field that runs from therapeutic apps to AI-supported assessment tools.

The MHRA lists four objectives:

  • helping developers interpret regulatory requirements and build compliance into product design at an earlier stage;
  • identifying challenges that innovators share, particularly small and medium-sized enterprises entering the mental health space;
  • sharing real-world experience from organisations already working through regulatory pathways;
  • strengthening dialogue between industry and regulators so that emerging technologies meet safety, performance and evidence expectations.

Survey to shape initial priorities

To decide where the community should start, the MHRA has opened a survey for digital mental health technology developers and other stakeholders in the medtech ecosystem. It asks about current regulatory difficulties, the areas where clearer guidance is needed and ways to improve compliance support.

The agency says broad participation matters so that the community reflects real-world needs rather than top-down assumptions, and it encourages developers to complete the survey and share the link within their organisations.

SH

Samira Hale

Samira Hale covers sterile consumables, endoscope reprocessing, autoclave systems, and infection-control procurement as an infection control, quality, and procurement editor for institutional readers. Her assessments examine validated reprocessing cycles, sterility assurance evidence, autoclave temperature and pressure parameters, service contracts, and life-cycle purchasing criteria without claiming laboratory findings. She helps sterile processing managers, infection prevention teams, and procurement specialists compare compliance evidence, maintenance obligations, and total cost of ownership while excluding individualized clinical advice and consumer shopping guidance.

📑 In This Article